Answer all your burning questions (and your patients’ burning questions) about the different COVID-19 vaccines currently authorized in the US. Infectious diseases / HIV expert, Dr Monica Gandhi @MonicaGandhi9 (UCSF) joins us to cover: the Pfizer-BioNTech and Moderna novel mRNA vaccine mechanisms, trial data, and practicalities of who should receive them. We discuss data around the Oxford-AstraZeneca adenovirus vaccine, which is authorized in the UK and India, and may be available in the US later this year. Feel confident recommending COVID-19 vaccines to your patients!
Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | [email protected] | Free CME!
Written and Produced by: Molly Heublein, MDCover Art: Chris Chiu, MD, FACP, FAAPInfographic: Tima KarginovHosts: Chris Chiu, MD, FACP, FAAP; Molly Heublein, MD; Paul Williams, MD, FACPEditor: Emi Okamoto MD (written materials); Clair Morgan of Nodderly.com (audio)Guest: Monica Gandhi, MD, MPH
Sponsor: Panacea Financial
This episode is supported by Panacea Financial, digital banking built for doctors, by doctors. At Panacea Financial you can have your own free personal banker and a support team that works around the clock- just like you do. Open your free checking account today at panaceafinancial.com
Panacea Financial, a Division of Sonabank, Member FDIC
Sponsor: VCU Health CE
The Curbsiders are partnering with VCU Health Continuing Education to offer FREE continuing education credits for physicians and other healthcare professionals. Visit curbsiders.vcuhealth.org.
Intro, disclaimer, guest bio - 00:00 Guest one-liner, book recommendation - 3:40
Authorized vaccines in the US - 8:30AstraZeneca vaccine mechanism- 9:26mRNA vaccine mechanism - 10:30Vaccine distribution issues (cold chain) - 16:05mRNA safety - 18:24mRNA vaccine efficacy/data from phase 3 trials - 19:40How did we get this so quickly - 23:40Vaccine impact on asymptomatic infection - 26:18AstraZeneca trials - 28:20Pregnancy - 35:10Anaphylaxis - 37:10Prior COVID-19 infection - 39:07Side effects - 42:05Pediatric patients - 45:12Phases of role outs in the US -46:50Herd immunity - 48:16Thoughts of how to make this happen - 52:45Preexisting conditions - 53:40How long will immunity last - 57:15Mutant strains - 58:25Future of mRNA vaccines - 1:00:30Take home points and Outro - 1:02:12